CHEN YINLIN JACK 4
4 · Allogene Therapeutics, Inc. · Filed Aug 14, 2023
Insider Transaction Report
Form 4
CHEN YINLIN JACK
SVP, Finance
Transactions
- Award
Common Stock
2023-08-10+11,401→ 88,881 total - Award
Stock Option (Right to Buy)
2023-08-10+39,160→ 39,160 totalExercise: $4.21Exp: 2033-08-10→ Common Stock (39,160 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option shall vest on August 10, 2024, and the remaining shares shall vest in 36 equal monthly installments thereafter.